150 related articles for article (PubMed ID: 36971780)
1. Cancer in Ecuadorian subjects with Laron syndrome (ELS).
Guevara-Aguirre J; Peña G; Pazmiño G; Acosta W; Saavedra J; Lescano D; Guevara A; Gavilanes AWD
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36971780
[TBL] [Abstract][Full Text] [Related]
2. Despite higher body fat content, Ecuadorian subjects with Laron syndrome have less insulin resistance and lower incidence of diabetes than their relatives.
Guevara-Aguirre J; Procel P; Guevara C; Guevara-Aguirre M; Rosado V; Teran E
Growth Horm IGF Res; 2016 Jun; 28():76-8. PubMed ID: 26259979
[TBL] [Abstract][Full Text] [Related]
3. Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.
Guevara-Aguirre J; Bautista C; Torres C; Peña G; Guevara C; Palacios C; Guevara A; Gavilanes AWD
Rev Endocr Metab Disord; 2021 Mar; 22(1):59-70. PubMed ID: 33047268
[TBL] [Abstract][Full Text] [Related]
4. Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency.
Guevara-Aguirre J; Rosenbloom AL
Diabetologia; 2015 Jan; 58(1):37-42. PubMed ID: 25316432
[TBL] [Abstract][Full Text] [Related]
5. Cancer in growth hormone excess and growth hormone deficit.
Guevara-Aguirre J; Peña G; Acosta W; Pazmiño G; Saavedra J; Soto L; Lescano D; Guevara A; Gavilanes AWD
Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37428642
[TBL] [Abstract][Full Text] [Related]
6. GH Receptor Deficiency in Ecuadorian Adults Is Associated With Obesity and Enhanced Insulin Sensitivity.
Guevara-Aguirre J; Rosenbloom AL; Balasubramanian P; Teran E; Guevara-Aguirre M; Guevara C; Procel P; Alfaras I; De Cabo R; Di Biase S; Narvaez L; Saavedra J; Longo VD
J Clin Endocrinol Metab; 2015 Jul; 100(7):2589-96. PubMed ID: 25985182
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity.
Guevara-Aguirre J; Teran E; Lescano D; Guevara A; Guevara C; Longo V; Gavilanes AWD
Growth Horm IGF Res; 2020 Apr; 51():58-64. PubMed ID: 32145513
[TBL] [Abstract][Full Text] [Related]
8. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
Rosenbloom AL
Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
[TBL] [Abstract][Full Text] [Related]
9. Laron syndrome - A historical perspective.
Laron Z; Werner H
Rev Endocr Metab Disord; 2021 Mar; 22(1):31-41. PubMed ID: 32964395
[TBL] [Abstract][Full Text] [Related]
10. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) insensitivity and insulin-like growth factor-I deficiency in Inuit subjects and an Ecuadorian cohort: functional studies of two codon 180 GH receptor gene mutations.
Fang P; Girgis R; Little BM; Pratt KL; Guevara-Aguirre J; Hwa V; Rosenfeld RG
J Clin Endocrinol Metab; 2008 Mar; 93(3):1030-7. PubMed ID: 18073295
[TBL] [Abstract][Full Text] [Related]
12. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
Janecka A; Kołodziej-Rzepa M; Biesaga B
In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
[TBL] [Abstract][Full Text] [Related]
14. MECHANISMS IN ENDOCRINOLOGY: Transient juvenile hypoglycemia in growth hormone receptor deficiency - mechanistic insights from Laron syndrome and tailored animal models.
Hinrichs A; Renner S; Bidlingmaier M; Kopchick JJ; Wolf E
Eur J Endocrinol; 2021 Jul; 185(2):R35-R47. PubMed ID: 34048365
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance depends on GH counter-regulation in two syndromes of short stature.
Guevara-Aguirre J; Guevara A; Bahamonde M
Growth Horm IGF Res; 2018 Feb; 38():44-48. PubMed ID: 29306561
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
[TBL] [Abstract][Full Text] [Related]
17. Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation.
Werner H; Sarfstein R; Nagaraj K; Laron Z
Cells; 2020 Nov; 9(11):. PubMed ID: 33182502
[TBL] [Abstract][Full Text] [Related]
18. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
[TBL] [Abstract][Full Text] [Related]
19. Identification of signaling pathways associated with cancer protection in Laron syndrome.
Lapkina-Gendler L; Rotem I; Pasmanik-Chor M; Gurwitz D; Sarfstein R; Laron Z; Werner H
Endocr Relat Cancer; 2016 May; 23(5):399-410. PubMed ID: 27090428
[TBL] [Abstract][Full Text] [Related]
20. Novel growth hormone receptor gene mutation in a patient with Laron syndrome.
Arman A; Yüksel B; Coker A; Sarioz O; Temiz F; Topaloglu AK
J Pediatr Endocrinol Metab; 2010 Apr; 23(4):407-14. PubMed ID: 20583548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
